Jesse Ikeme
@j_ikeme
Followers
93
Following
5
Media
4
Statuses
20
Nephrology fellow @UCSFNephrology, @UCSFIMChiefs and @Stanford alum. Views are my own.
San Francisco, CA
Joined April 2017
The effect of sodium-glucose co-transporter-2 inhibitors (SGLT2i) on cardiovascular disease and CKD may be limited if discontinued in persons with CKD. This study found that a substantial proportion of patients experience SGLT2i discontinuation within a year of initiation.
2
25
61
Fellow UCSF nephrons checking out Jesse Ikeme’s work on plasma and urine UMOD and its association with kidney outcomes in SPRINT.
0
4
11
The Association of Plasma and Urine Uromodulin With Cardiovascular Disease in Persons With Hypertension and CKD https://t.co/jFsFQMRY6s (FREE) @j_ikeme @pranavgarimella @estrella_khrc @shlipak_khrc @UCSFNephrology @KHRC_research #CVD
0
8
19
Celebrating our AMAZING graduating fellows! Cheers to a night filled with fun and laughter!(1/2)
1
2
17
Celebrating scientific success! Representing UCSF at #NKFClinicals #NKFSCM2024 proud of our current and future fellows! @PeschardGiselle @MPostalcioglu @j_ikeme
0
4
18
Enjoyed writing this @NEJM Letter to the Editor with Tom Newman & Michael Kohn @UCSF_Epibiostat. And appreciate the authors' response!
nejm.org
To the Editor: In the Use of Copeptin Measurement after Arginine Infusion for the Differential Diagnosis of Diabetes Insipidus (CARGOx) trial (Nov. 16 issue),1 Refardt and colleagues evaluated the ...
0
1
7
Dr Jesse Ikeme @UCSF senior research fellow at his nice #KidneyWk poster on uromodulin and CVD outcomes in the SPRINT study @KHRC_research @estrella_khrc @shlipak_khrc
0
4
22
Thank you 2022-2023 Chief Fellows for your hard work and leadership!
0
1
12
Welcome back to #AJHTweetorials This week we will discuss https://t.co/A03j1pjIu2 which was the #EditorsChoice from @ESchiffrin Authors @shlipak_khrc @estrella_khrc @Ndichu_Muiru @KHRC_research @krihsd @pranavgarimella 1/
academic.oup.com
AbstractBACKGROUND. Urine biomarkers of kidney tubule health may distinguish aspects of kidney damage that cannot be captured by current glomerular measure
1
4
5
#MedTwitter I’m excited to share a project near and dear to my ❤️ : Huppert’s Notes! https://t.co/wyoGwocafm A thread 🧵...
19
49
301
Proud to be able to comment on this issue with @JamesSalazarMD and @RWGrantMD in @JAMAInternalMed. "Reappraising Medical Syntax—Does Race Belong in the First Line of the Patient History?"
0
3
16
Hidden in Plain Sight — Reconsidering the Use of Race Correction in Clinical Algorithms | NEJM; Caution to all researchers and clinicians on the harms of race correction in dx and predictive tools @j_ikeme @RWGrantMD 1/5
2
1
1
Done with med school! Grateful for the village that helped me get here. It's truly an honor to have you behind me.
0
2
16
Congrats to my mentor, @Peralta_KHRC for promotion to full professor! 🎉🎉🎉 I'm lucky to be among the many at UCSF infected by your passion
Congratulations to one of the most inspiring, hardworking, tenacious people I know. @Peralta_KHRC promoted to Full Professor, effective July 1 🙌🏽 #KHRC @UCSFNephrology
0
0
5
Thrilled to learn I will be staying at UCSF for internal medicine residency! Thank you all who have supported me along the way.
0
0
3
Had a great time in New Orleans at my first @ASNKidney #KidneyWk. So much exciting work being done!
0
0
2
0
3
9
Inspired by my colleagues and Dr. @vivek_murthy this morning. Congrats @ucsfmedicine class of 2017!
0
2
10
Enjoyed presenting our clopidogrel study at the @UCSF Inquiry Symposium! https://t.co/t0hGpbe33r
0
1
1
Really proud of my first paper with @Peralta_KHRC in @CJASN!
Post Hoc Analyses of RCT for Effect of Clopidogrel Added to Aspirin on Kidney Function https://t.co/BjLzDM1ldP
@j_ikeme @Peralta_KHRC
0
0
0